Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,275,345 papers from all fields of science
Search
Sign In
Create Free Account
Glucagon-Like Peptide-1 Receptor
Known as:
GLP 1 Receptor
, Glucagon-Like Peptide-1 Receptor [Chemical/Ingredient]
, GLP 1R Receptor
Expand
A receptor for GLUCAGON-LIKE PEPTIDE 1 (GLP-1) expressed primarily on the surface of beta and ductal exocrine cells of the pancreas, as well as cells…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
In Blood
agonists
antagonists & inhibitors
aspects of radiation effects
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
T. Vilsbøll
,
M. Christensen
,
A. Junker
,
F. Knop
,
L. Gluud
British medical journal
2012
Corpus ID: 1077064
Objective To determine whether treatment with agonists of glucagon-like peptide-1 receptor (GLP-1R) result in weight loss in…
Expand
Review
2012
Review
2012
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
J. Meier
Nature Reviews Endocrinology
2012
Corpus ID: 10646511
In healthy humans, the incretin glucagon-like peptide 1 (GLP-1) is secreted after eating and lowers glucose concentrations by…
Expand
Review
2011
Review
2011
Long-Acting Glucagon-Like Peptide 1 Receptor Agonists
A. Garber
Diabetes Care
2011
Corpus ID: 12306315
Targeting the incretin system has become an important therapeutic approach for treating type 2 diabetes. Two drug classes have…
Expand
Highly Cited
2010
Highly Cited
2010
Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation.
L. Bjerre Knudsen
,
L. Madsen
,
+16 authors
U. Moerch
Endocrinology
2010
Corpus ID: 20934882
Liraglutide is a glucagon-like peptide-1 (GLP-1) analog developed for type 2 diabetes. Long-term liraglutide exposure in rodents…
Expand
Highly Cited
2010
Highly Cited
2010
Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
M. Arakawa
,
T. Mita
,
+7 authors
H. Watada
Diabetes
2010
Corpus ID: 77793
OBJECTIVE Exogenous administration of glucagon-like peptide-1 (GLP-1) or GLP-1 receptor agonists such as an exendin-4 has direct…
Expand
Highly Cited
2009
Highly Cited
2009
Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
B. Zinman
,
John E. Gerich
,
+6 authors
L. Blonde
Diabetes Care
2009
Corpus ID: 16101900
OBJECTIVE To determine the efficacy and safety of liraglutide (a glucagon-like peptide-1 receptor agonist) when added to…
Expand
Review
2006
Review
2006
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
D. Drucker
,
M. Nauck
The Lancet
2006
Corpus ID: 25748028
Highly Cited
2002
Highly Cited
2002
Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons.
Hiroshi Yamamoto
,
Charlotte E. Lee
,
+8 authors
J. Elmquist
Journal of Clinical Investigation
2002
Corpus ID: 14179732
Glucagon-like peptide-1 (GLP-1) released from the gut functions as an incretin that stimulates insulin secretion. GLP-1 is also a…
Expand
Highly Cited
1999
Highly Cited
1999
Distribution of pre‐pro‐glucagon and glucagon‐like peptide‐1 receptor messenger RNAs in the rat central nervous system
I. Merchenthaler
,
M. Lane
,
P. Shughrue
The Journal of comparative neurology
1999
Corpus ID: 45282378
Glucagon‐like peptide‐1 (GLP‐1) is derived from the peptide precursor pre‐pro‐glucagon (PPG) by enzymatic cleavage and acts via…
Expand
Highly Cited
1996
Highly Cited
1996
Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor.
B. Bullock
,
R. Heller
,
J. Habener
Endocrinology
1996
Corpus ID: 23080390
The incretin hormone glucagon-like peptide-1 (GLP-1) is an important regulator of postprandial insulin secretion. In addition to…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE